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Human dermal microvascular endothelial cells par-
ticipate in activities including inflammation, wound 
healing, and angiogenesis (neovascularization). Two 
stages of angiogenesis can be 111.imicked ill l1itro by two 
models of cultured foreskin human dermal microvas-
cular endothelial cells: the differentiation of epithe-
lioid endothelial cells to spindle-shaped mesenchy-
mal-like cells induced by phorbol ester treatment; 
and the formation of vascular cha11l1els induced by 
exposing the luminal surface of endothelial cell 
monolayers to type I collagen gels. The mechanisms 
underlying these two processes, however, are largely 
unknown. Protein kinase C isozymes, which are ac-
tivated by phorbol esters, are important mediators in 
the angiogenic process. In the current work, we 
identified the protein kinase C isozymes present in 
human dermal microvascular endothelial cells and 
determined which of the isozymes are activated in 
response to phorbol ester or to collagen treatments. 
O ne of the first steps in angiogenesis is the conver-sio n of microvascular endothelial cells from the typical epith elio id confi guration to mesenchymal-like, spindle- shaped cell s (Karasek, 1991). T his step precedes the mi gration of human derm al 
microvHscul ar endo th elial ceUs (HDMEC) and formH tio n of vascu-
lar channe ls. 
Earlier studies demonstrated that both large vesse l cells and 
microvascular cells undergo a rapid change from an epitheHoid to a 
spindl e-shaped m orpho logy when treated with a pho rbo l ester o r 
cytokines (Antonov el nl, 1986; Lip ton ct nl, 1991). T here is also a 
strikin g change in morphology and the growth pattern of cell s 
when the luminal surface of a confluent culture is covered with a 
co llagen gel: HDM.EC differe ntiate within 4 h to form vascul ar 
channels (Kramer ct nl, 1987) . T he biochemical m echanism s un-
derl ying the intracellular signaling events in volved in this differen-
tiation arc unknown . 
Protein kinase C (PKC) is a key enzym e in sign al trHnsdu ction 
regula ting cell growth (Olson el al. 1993), cell di.lferen tia tion 
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Using western blot analysis, we found that microvas-
cular endothelial cells contain at least six protein 
kinase C isozymes (a, 13, 0, E, ~, 1'). Immunocyto-
chemical studies demonstrated that the isozymes are 
located in distinct cellular compartments and that 
following treatment with phorbol 12-myristate 13-
acetate or with a collagen gel overlay, most isozymes 
(protein kinase C a, 131, 1311, 0, E, 11) translocated to 
different parts of the cell. Moreover, for two of these 
isozymes (1311 and 11), the localization differs after 
phorbol 12-myristate 13-acetate treatlnent as com-
pared with collagen treatment. These results demon-
strate that agents that mimic two stages in the angio-
genic process in l1itl'O initiate diverse changes in the 
subcellular localization of specific protein kinase C 
isozymes and suggest a role for different isozymes in 
this process. Key 1I100'ds: h",IIa.ll de 1'111 a I lIIicrOl1aSCllla r 
eudotllelial cells/angiogenesis. ] !lI.l1est Del'tllatoi 107:248-
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(Saxon el nl, 1994), and gene expression (B lackshear el nl, 1988) . 
The activation of PKC by {3-pho rbo l '12-lllyristate 13-acetate 
(PMA) in hum an umbiljca l ve in endothelial cells has been shown to 
be req uired for the differentia tion of these cells to capillary-like 
structures when cul tured in the presence of Matrigel and in the 
absence of serum (Kinsella el nl, 1992). In additi on, PKC appears to 
regula te the expressio n and rearrangement of adhesion m o lecules 
on endothelial cells (Sung c/ (II, 1994) and the retraction of large 
blood vesse l endothelial cells by lipoxygenase metaboli tes (Tang et 
nl, 1993 ). 
PKC constitutes a fami ly (a. {3 l , {3 11, 'Y. 8. E, ~. 1], (~, A, and iJ.) of 
re lated isozymes (Nishizuka, 1988, 1989). They consist of a single 
po lypeptide with an amino-terminal regu];itory domain and a 
carboxy-terminal catalyti c domain (Kikkawa cI nl, 1987; O no el (II, 
1988) . D ifferences in tissue distribution, subcellular localization, 
and translocation fo llowin g Hctivation ha ve also been d em onstrate d 
(Moch ly-Ko sen c( al. 1990; Disatnik ci nl, 1994). Previo lls studies 
regarding the expression of PKC isozymes ill bov in e aortic endo-
thelia l cells (R.osales el nl, 1992) , and human umbilica l vein 
end othe lial cells (De isher el nl. 1993) have been performed using 
anti-a. - (3. and - 'Y PKC antibodies. These studies in large blood 
vessel cells al so demonstrHted tha t indi vidual isozymes have difFer-
en t translocatiOli patte rns upon activation . Indi vidual isozymes ar e 
like ly to play a distinct ro le in signal transduction and therefore 
influence different ce ll fun ctions. 
We used isozyme- specifi c PICC antibod ies to identi f)' the PKC 
isozym es present in hum an de rmal microvascular endothelial cells. 
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Since translocation of PKC upo n stimula tion is thought to indicate 
activa tio n , we studied the translocatio n of PKC isozymes indu ced 
by either PMA treatme nt o r collagen overlay o n culture d HDMEC. 
We found that at least six PKC isozymes are present in HDMEC (a, 
(3, 8, E, ~, TJ), and that the isozym es h ave di stinct subcellul a r 
localizations. With only one e x ception (PKC 0, all of the PKC 
isozym es tra n slocated to a diffe re nt subcellular location after treat-
ment with PMA or collagen. 
MATERIALS AND METHODS 
Materials PKC isozyme-specific anti bodies (anti-a, -(3. and -')' PKC 
mo noclonal antibodies and anti-o, -E, -{, and -1') PKC polyclonal antibodies) 
used for immunocytochemistry were purchased fi'om R.e search and Diag-
nostic Antibodies (Berkeley. CAl. Polyclo nal antibody anti-O PKC was from 
Santa Cruz Biotechnology (Santa-Cruz, CAl. Fluoresce in-conjugated anti-
rabb it IgG antibodies prepared in goat were from Organon Technika Corp . 
(West C hester, PAl. For western blot analyses, an ti-a, - {3. and -1' PKC 
monoclonal antibodies were from Seikagaku America Inc (R.ockv ille. MD), 
and anti- I>, -E, and -{ PKC polyclo nal anti bodies we re 6'om GIBCO BtU 
(Gai thersburg, MD). Anti-1') PKC was obtained from R.esearch and Diag-
nostic Antibodies (Berkeley, CAl . Anti-O PKC waS fro m Santa C ru z 
Biotechnology (Santa Cruz , CAl. R.abbit antiserum to mouse IgG was from 
O rganon Teknika Corp . (Durham. NC). Glass slides with eight chambers 
came fro m Nunc, Inc. (N aperville. IL) . a PMA was from LC Laboratories 
(Woburn, MA) . PMA was purchased from Sigma C hemical Co. (St. Lou is. 
MO). Collagen was from Celtrix (Santa C lara. CAl . [, 25 1jprotein A was 
from ICN Pharmaceuti cals, Inc. (Irvine, CAl. 
Cell Culture Human derm al microvascular endothelial ce lls were iso-
lated from neonata l human foreskin as previously described (Karasek. 1989). 
Using gelatin-coated plastic flasks, ce lls were grown in a complete media 
containing modified Iscove's growth media supplemented with 8% new-
born calf serum, 2% human prepartum matemal serum, 1.3 X 10 - 4 M 
dib utyryl cAMP, 3.3 X 10- 5 M isobutyl methylxanthine, 1 X 10- 4 M 
hypoxanthine, and 1. 5 X 10- 5 M thymidine. Cell s were fed twice each 
week and wcre trypsin.ized using 0. 10;., trypsin and 1 '}'I, ethylenediamine 
tetraacetic acid when cell s became conAuent. Second through fourt h 
generations of HDMEC were routine ly used in all experiments. Approx i-
mately 95% of ce lls expressed specifi c antigens in endotheli al cell s including 
facto r VlIl and platelet endotheli al ce ll adhesion molecule . For PKC 
translocation studies , approximate ly 3000 ceUs per chamber were seeded o n 
glass chamber sl.ides coated with l tV" of gelatin. Cells were fed twice each 
week with complete medium until they reached 95-1 00% confluency. 
Western Blot Analysis Confluent ce lls cul tured in 75-rnm Aasks were 
washed twice with phosphate- buffered sa linc (PBS) and scraped on ice into 
1 rnl of buffer contai ning 20 mM Tris(hydroxym ethyl)aminomethanc-HCl. 
pH 7.5, 2 mM ethylenediamine tetraacetic acid , 10 mM cthyleneglycol-
bis({3-aminoethyl ether) - N .N, N' ,N ' -tetraacetic acid. 20 }.Lg aproti nin per 
ml , 20 fJ.g leupeptin per ml , 20 }.Lg soybean trypsin inhibi tor pCI' ml , and '10 
}.LM phenylme thylsulfonyl fluoride. T he cell suspension was passed through 
a 25-gauge needle five tim es, and samples (50 }.Lg/ lane) were subjected to 
10% sodium dodecyl sul f.1te -polyacrylamide gel electrophoresis followed by 
e lectro blotting onto a nitrocellulose m embrane. T he membrane was sub-
sequently incubated for 2 h in a blocking so lution containing 5% dried mil k 
in PBS containing 0 .05% Tween 20. PKC isozyme leve ls were determined 
using anti-a, - {3 (which recognize both {3I, (3 II PKC isozym es), or - ')' PKC 
monoclonal antibodies diluted 1: 1 000 fo llowed by 1-" incubation witll 
rabbit anti-mo use antisera (1:1000), or anti-o, - E, -{, -1'), o r 0 PKC 
polyclonal antibodies diluted 1 :300 . All membranes wcre then incubated 
w ith [ ' 25 Ijprotcin A, and PKC immuno reactive bands were detected by 
a utoradiography. 
Im.munolocalization ofPKC Isozymes C ells grown in gelatin-coa ted 
cbamber slides were washed three times (I h each) with serum-free 
complete medium to eliminate serum; cell s were then treated with 0,1 }.Lg 
PMA per ml (162 nM) for 10 min or with co llagen overlay (contain.ing 50% 
vo l/vol Vitrogen 100, 50% vol/vol C\"ice concentrated Dulbccco's modi-
fied Eagle's medium, and 1% vol/vol 0.5 N NaOH. final pH 7.4) for 30 min 
to allow complete gelation of collagen (Lipton et ai, 1991). Negative contro ls 
we re trea ted w ith 4-a PMA, a biologically inacti ve pho rbol ester. After 
treatment, cells were washed once with PBS , fixed for 3 min in a .1:1 
mixtu re of acetone-methanol at - 20°C, and subsequentl y w"shed twice 
w ith PBS. Cells were then incubated at room temperature for 1 Ii w ith 1% 
normal goat serum in PBS conta ining 0. 1 % Triton X I00 in order to 
minimize nonspecific binding. Cell s w ere then incubated overnigh t at 4°C 
with the PKC isozyme-specifi c antibodies diluted 1:'100 in PBS containing 
0. 1 % Triton X100 and 2% bo vine serum albumin. Cell s were washed three 







Figure 1. Inununoblot analysis of different PKC isozymes (pKC a, 
(3, ,)" 0, E. ?:. '1'/ and 0) in HDMEC . Toral proteins (50 }.Lg per lan e) from 
HDMEC w ere tra nsferred to a nitrocellulose m embrane fo llowing sodium 
dodecyl su lfate- polyacrylamide gel electrophoresis (10% ge l). The molec-
ular ma~s marke rs were myosin (200 kDa). phosphorylase (97 kDa). bovine 
serum (69 kDa), and ovalbumin (45 kDa). 
times with PBS containing 0.1 % Triton X l 00 and incubated for 2 h with 
Auo rescein-conj ugated anti-rabbit IgG antibody diluted 1 :1000 in PBS 
conta.ining 0.1 % Triton X I OO. After three was hes with PBS, slides were 
mounted using Miowiol 4-88 (Calbiochem, La Jolla, CAl as described 
previously (Disatnik er al. 1994). A Zeiss IM35 microscope with a 40 X 
water immersion obj ective (Cad Zeiss, Inc .. T hornwood, NY) was used to 
record images on Kodak T ri-X pan film with an exposure time of 45 s. 
Specifi city of the staining obtained using different anti-PKC isozyme 
antibodies was determined by pre- absorption of the 0' . {3I , {3U, 0. E, { . or 1') 
antibodies (1:100) w ith their immun izing peptides (1 fJ.g/ }.LI) for 4 h at 4°C 
(Disatllik et al. 1994). N o specific staining was fo und after pre-absorption or 
in cells stained in the absence of the PKC antibodies (data not shown). 
RESULTS 
Identification of PKC Isozymes Present in Human Dermal 
Microvascular Endothelial Cells PKC isozyme expression in 
human dermal microvascular e ndothe lial cell s was examin ed by 
western bl ot analysis u sing isozym e- specific anti-a, -(3, and -I' PKC 
monoclona l antibodies o r anti- a, -E, - " -1), and - {J PKC polyclonal 
antibodies . l' and {J PKC isozymes were not found ill HDMEC 
extracts (Fig 1) . In contrast to these two isozymes, immunoreactive 
bands of six PKC isozymes, a, {3, 8, E, " and TJ, were clearly 
detected (Fig 1). Isozymes a , 8, and TJ h ad apparent mol ecular 
masses of 82, 72, and 80 kDa, respective ly. PKC {3 was recognized 
as a protein with doublet bands of 76 and 78 kDa, w hereas PKC , 
was detected as 75- and 82-kDa b and s. A PKC E immunoreactive 
band was d etecte d at about 92 kDa. A minor band of 56 kDa of E 
PKC immunoreactivity w as also found . 
Localization ofPKC Isozymes in Human Dermal Microvas-
cular Endothelial Cells To d e te nnine PKC isozyme localiza-
tion in HDMEC, w e perforn1ed immunofluorescence analysis using 
isozym e- specific antibodies as previously reported (Mochly-Rosen 
er ai, 1990; Disatnik et ai, 1994). T his technique provides informa-
tio n regarding subce llular loca lization and redistribution of diffe r ent 
isozym es at t h e level of indiv idua l ce ll s . To verify the specific ity of 
each isozym e, immuno fluorescence staining was tested by using 
PKC isozym e-specific antibodies p rea b sorb ed with the ir respective 
immunizin g peptid es. Afte r preabsorption, no staining was ob-
served (data not sh own). These results are similar to those observed 
in cardiac m yocytes (Disatnik el ai, 1994). 
When sta ining of nonstimulated HDMEC was examined using 
the anti-I' and anti-{J PKC antibodies, n o staining was detected 
(data n ot sh own). T hese findings confiml the western blot data in 
whic h the l' and {J PKC immunoreactivi ties were absen t. 
T h e immuno reac ti v ity of a PKC appeared as diffuse staining 
throughou t control (untreated) cells (Fig 2A) . Some nuclear 
sta ining was a lso observed. After treatment with PMA or coll agen 
overlay, similar r esul ts were o b tain ed , as sh own in Fig 2B and 2e. 

























-• tit • 














.:. e .... 
I . • - .~ :-. • 
. .... .. 
. .. " I •• ~. .."-t 
F ig ure 2 . Immunofluorescence localization of 0', {3I, and {3II PKC in HDMEC. Cell s were fixed and stained with isozym e-specif ic an tibodies as 
described in Materials alld M etltods. A, D, and C, nonstim ulated ce ll ; B, E. and H. PMA-treated cells (0.1 /Lg per mi. 10 min): C . F. and I, cell s overlayed 
w ith co ll agcn for 30 min. Senle bar, 5 /Lm. The .::> ill C indicates thc stainin g at the perinuclear regio n. T he ¢ in H indicates the fi lam en to us staining. 
Cytosolic staining and especially nuclear staining were redu ced, and 
a peri-nuclear staining pattern appeared (Fig 2C, afrOIIJ). 
Anti-i3I staining wa s fib rillar in the cytoplasl11 and diffu se in the 
nucleus in contro l cells (Fig 2D) . T he intranuclear staining in-
creased and cytoplasmi c staining decreased after activation induced 
either by PMA or by coll agen overlay (Fig 2E, 2F). T he {3II PKC 
immunostaining was predominantly located in th e intranuclear 
region of the con trol cells (F ig 2G). After treatment w ith PMA, the 
in tranuclear staining decreased and the fi lamento us staining in the 
cytoplasmi c region was 11101'e in tense than tha t found in untreated 
cells (Fig 2H, arrolll) . T he translocation of {311 PKC was more 
pronounced w hen cell s were treated with collagen. T he immuno-
staining of the nucleus observed in contro l cells (Fig 2G) was 
replaced with in tense perinuclear staining (see ring-like structure in 
Fig 21. an-olll). In addition, filamentou s staining was also observed 
(Fig 21). T herefore, the loca lization of {3Il PKC following collagen 
and PMA treatments differed. 
When HDMEC were examined using the anti-a PKC antibody, 
the iml11un olocalization of aPKC was primarily cytosolic and 
fibrill ar (Fig 3A). After exposure to PMA (Fig 3B) or collagen (Fig 
3C), tbe filamentous staining was more apparent in both situations 
(see arrows in Fig 3B and 3C) . T hese staining pattern s were sim.ilar 
to the ones obtained w ith an ti- , PKC antibodies in either nonstimu-
lated (Fig 3D) or stimulated cells (Fig 3E, 3F) , indica ting that 
there was no trans location of , PKC following either treatment. 
T he staining of control cells using anti-e PKC antibody was 
diffuse in the cytoplasm and dotted in the periphery of the cells (Fig 
4A) . In one half of the cultures, more intranuclear stai.ning was 
observed, and the sta ining at the cell periphery was continuo us (Fig 
4a, slllall (Jmllll) rather than dotted (Fig 4A). T his pronounced 
periphe ral sta ll1L11 g pattern (Fig 4A, 4a, nrroills) was unique for E 
PKC and disappeared following treatmen t with either PMA or 
collagen, whereas the cytosolic staining was only sli ghtly decreased 
(Fig 4B and 4C) . In additio n , perinucl ear staining was m ore 
apparent in cells stimulated with PMA o r collagen. 
T he stainin g of con trol cell s using anti-T) PKC antibody w as 
localized in the cytoplasm as we ll as in the nuclear region. Mter 
treatment with PMA (Fig 4E), the nuclear staining was reduced 
and perinuclear stainin g appeared. T his perinuclear stainin g was not 
o bserved, however, in collagen-tre;lted cells (Fig 4F) , and the 
overall staining of collagen-treated cells resembled that of control 
cell s (Fig 4D). T herefore , T) PKC translocated fo llowing PMA 
treatment but not following coHagen overlay. 
We also carried o ut immunofluorescence analysis of cells treated 
w itb 4-aPMA, the biologically inactive derivative of PMA. For 
each isozym e, no redistribu tion was observed following treatment 
with 4- aPMA (0.1 J.Lg per m l for 10 min); the immunostaining of 
control cells and cells treated with 4- a PMA was identical (data nor 
shown). 
Table I summarizes the results obtain ed by immunofluorescence 
analys is of th e seven isozymes found in HDMEC. T he data show 
that PKC isozym es are located in distinct cellul ar compartments 
before and after activation with PMA and colla gen. 
DISCUSSION 
A link between angiogenesis and PKC activation has been sug-
gested (Ingber et aI, 1990). Usi.ng the cluck chorioallantoic m em-
brane, Tsopan oglou et al (l993) demonstrated that PKC inhibitors 
ca n reverse the angiogeni c elfects induced by PMA. PKC m ay also 
play an important role in the function s of a number of skin cell types 
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Conlrol PMA Collagen 
Figure 3. Immunofluorescence localization ofPKC [) and ~ in HDMEC. Cell s were fix ed and stained w ith isozyme-specific antibod ies as described 
in M aterials mill Methods. A and D, nOll stimulated ce lls; Band E, PMA-treated cell s (0.1 fLg per ml , 10 mill) ; C and F. ceLi s overl ayed with collagen for 30 
min. Scale bar, S fLlTl. T he <:,') in C and D ind icate the filamentous sta ining. 
including th e k e ra till ocyte (O 'Driscoll et aI, 1994), and the micro-
vascular endothelial ceU (Davis et (/1, 1993). In human mnbiJica l 
vein endothe lial ceUs, vitron ectin , o ne of the cell adhesion m o le-
cules implicated in the process of capillal'y-like stru cture forma tion. 
appears to be a substra te for PKC (Davis et ai, 1993). 
In the curre nt study, we used two indep endent m eth od s to show 
that multipl e PKC iso zym es (ex, {31, {311 , 8, E, ~, and 7) are present 
in hum an d emJalmicrovascula r endothelial ce lls. The data o btained 
wi th isozym e-specific antise ra , both b y western blot 'lila lys is (Fig 1) 
and by immunofluorescen ce studies (data not shown) , indi cated 
that isozym es y and e wel'e undetectabl e even unde r a variety of 
primary and secondary antibody dilutio n s. It is unlik ely that the 
negative signals fo r both isozym es in w estern blot analysis and in 
Control PMA 
immuno flu o rescen ce studies re fl ect a weak specificity for these two 
antibodies rather than ' I tru e absen ce of these isozym es at the 
protein level in H DMEC, beca use the sam e antibodies readily 
detected y PKC in rat brain tissue (not shown) and in human T cells 
(Smith an d Mochly Rosen , ullpublished). T he lack of y and f) 
isozym es in HDMEC is in agreem e nt with oth er studies indicating 
that the PKC y isozym e is a brain-specitlc form (Nishizuka , 1988; 
Ono e/ aI, 1988), it cannot be de tec ted in bovine aortic endothe li al 
cells (Rosales c{ ai, 1992) , and that PK C f) was predomin antly 
expressed in h e m atopoetic cells (Baier et ai, 1993). 
It was not surprising to find that isozym e ~ failed to respond to 
PMA stimulation . Other studi es (Ono et ai, 1989; Nakan.ish ,U1d 
Exton , 1992) have suggested that ~ PKC h as several distinguishing 
Collagen 
F igure 4. Immunofluorescence localization ofPKC E and T/ ill HDMEC. Cell s were fixed and stain ed with isozym e-specific an tibodies as described 
in Materials O/Id Methods. II , a, and D , nonstimulated ce ll s; Band E, PMA-o'catcd ce lls (0. " fLl!: per ml , 10 min) ; C and F. ce lls overl ayed with co ll agen for 
30 min. Scale bar. 5 fLm. The <> in II and a indicatc the anti-E PKC sta ining at the ce ll periphery . 
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Table 1. Localization of PKC Isozymes Before and After 
Activation with Phorbol Ester (PMA) and Collagen 
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characteristics compared wi th other isozymes . Firs t , ~ PKC contains 
only one cysteine-rich zinc-fInger-like sequence w hereas o ther 
PKC isozymes have two repeats of this sequence. Second , C PKC 
docs not bind phorbol esters or diacylglycerol (Ono el ai, 1989) . In 
our study, , PKC did not respond to either PMA or coll agen 
stim ula tio n , suggesting that ~ PKC is probably not involved in 
HDMEC differentiation induced by PMA or collagen. 
The immunoAuoresence studies demonstrated that the localiza-
tion of the isozymes following stimul ation with PMA or collagen 
differed from that of untreated cells. T he trans location ofPKC has 
been noted in a number of cell types including bovine aortic 
endothelial cells (Rosa les et ai, 1992) and rat cardiac myocytes 
(Mochly-Rosen et ai, 1990; Disatnik e/ ai, 1994). As ha s been 
previously suggested (Mochly-Rosen, 1.995), it is like ly that the 
differentially localized isozymes phosphorylate nearby substrates. 
Further studies to identi fy isozyme-unique substrates at each of 
these isozyme sites are underway. 
Although (31 and (311 PKC arc derived /Tom alternative sp Li cin g of 
the same mRNA (Ono et ai, 1986) and differ in their C-termin al 
sequence by only 50 amino acid residues (Kubo et ai, 1987), they 
are differentially loca lized in HDMEC. T he immunostaining pat-
terns of (31 and (311 PKC isozymes in HDMEC differ from each other 
before and after activation (Fig 2D, E , and F Jlel"SIiS G, H , and 1). 
These results suggest that the C - terrninal sequence is essential for 
the localization of the activated isozym es and probably also the 
resulting fu nction of (31 and (3II PKC in HDMEC. A similar 
difference in (3I and (311 PKC translocation was also observed in 
primary cardiac myocytes when stimu lated with PMA or norepi-
nephrine (Disatnik ct ai, 1994) . 
O ur studies also demonstrate diIrerential responses of the 
isozymes to PMA and collagen . T he differences in localization of 
(311 and TJ PKC isozymes in response to PMA or collagen treatments 
are of particular interes t. T hey may provide a mechanism to explain 
w hy collagen treatment induces channel formation of endotheli al 
cells whereas PMA treatment induces the conversion of epithelioid 
endothelial cells to spindle- shaped m esenchymal-like cells. 
Differences in both the activation and translocation of PKC 
isozymes by phorbol esters and collagen gels, and the m aj or 
differences in the induction of new vessels by these agents , suggest 
an involvement of different protein receptors for PKC isozymes. 
T he development of speciflc translocation inhibitors of PKC 
isozymes m ay provide a new pharmacologic approach to th e 
control of an giogenesis (Mochly-Rosen, 1995) . 
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